MOLECULAR BIOMARKERS OF HUMAN DISEASE: FUNDAMENTAL CONCEPTS, RESEARCH MODELS AND CLINICAL APPLICATIONS

被引:0
作者
Zamora-Obando, Hans R. [1 ]
Godoy, Adriana T. [1 ]
Amaral, Alan G. [1 ]
Mesquita, Alessandra de S. [1 ]
Simoes, Bruna Eduarda S. [1 ]
Reis, Heloise O. [1 ]
Rocha, Isabela [1 ]
Dallaqua, Matheus [1 ]
Baptistao, Mariana [1 ]
Fernandes, Milena Cristina, V [1 ]
Lima, Monica F. [1 ]
Simionato, Ana Valeria C. [1 ,2 ]
机构
[1] Univ Estadual Campinas, Inst Quim, BR-13083970 Campinas, SP, Brazil
[2] Univ Estadual Campinas, Inst Nacl Ciencia & Tecnol Bioanalit, BR-13083970 Campinas, SP, Brazil
来源
QUIMICA NOVA | 2022年 / 45卷 / 09期
基金
巴西圣保罗研究基金会;
关键词
biomarkers; omics sciences; human diseases; ON-A-CHIP; METABOLIC FLUX ANALYSIS; FALSE DISCOVERY RATE; IN-SILICO MODELS; ALZHEIMERS-DISEASE; SYSTEMS BIOLOGY; CARDIOVASCULAR-DISEASE; PATHWAY ANALYSIS; COMPUTATIONAL CHALLENGES; ESSENTIAL-HYPERTENSION;
D O I
10.21577/0100-4042.20170905
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Molecular biomarkers correspond to all endogenous or exogenous biomolecules, whose presence or alteration in metabolic pathways indicate the response of a biological system to a disturbance caused by internal or external factors. The search for biomarkers has allowed deepening the knowledge of complex pathophysiological mechanisms of diseases, interactions with potential drugs, and the improvement of diagnostic and therapeutic tests, establishing itself as a central point in personalized medicine. In addition, the development of the omics sciences has fostered an increasing exploration in this field of research. This review presents essential and relevant concepts in biomarker research, explores the various definitions and classifications of biomarkers according to their purpose, the critical aspects to be considered in experimental design, the primary employed study models (in vivo, in vitro, and in silico) and the factors that have hindered their ultimate implementation. Finally, important, and current clinical and pharmacological research areas in which biomarker research play a central role are presented.
引用
收藏
页码:1098 / 1113
页数:16
相关论文
共 245 条
[1]  
Abdi H., 2007, ENCY MEASUREMENT STA, P103, DOI [DOI 10.4135/9781412952644, 10.4135/9781412952644]
[2]   Circulating mitochondria DNA, a non-invasive cancer diagnostic biomarker candidate [J].
Afrifa, Justice ;
Zhao, Tie ;
Yu, Jingcui .
MITOCHONDRION, 2019, 47 :238-243
[3]   Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer's disease [J].
Agostini, Alessandra ;
Ding Yuchun ;
Bai Li ;
Kendall, David A. ;
Pardon, Marie-Christine .
BRAIN BEHAVIOR AND IMMUNITY, 2020, 83 :87-111
[4]   Metabolomics analysis I. Selection of biological samples and practical aspects preceding sample preparation [J].
Alvarez-Sanchez, B. ;
Priego-Capote, F. ;
Luque de Castro, M. D. .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2010, 29 (02) :111-119
[5]   Essential hypertension: A filtered serum based metabolomics study [J].
Ameta, Keerti ;
Gupta, Ashish ;
Kumar, Sudeep ;
Sethi, Rishi ;
Kumar, Deepak ;
Mahdi, Abbas Ali .
SCIENTIFIC REPORTS, 2017, 7
[6]  
Amorim Leiliane Coelho André, 2003, Rev. bras. epidemiol., V6, P158
[7]   Methods and advances in metabolic flux analysis: a mini-review [J].
Antoniewicz, Maciek R. .
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2015, 42 (03) :317-325
[8]  
Arias, 2008, OECOLOGIA BRASILIENS, V12, P347, DOI DOI 10.4257/0EC0.2008.1203.01
[9]   Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery [J].
Aristoteli, Lina P. ;
Molloy, Mark P. ;
Baker, Mark S. .
JOURNAL OF PROTEOME RESEARCH, 2007, 6 (02) :571-581
[10]   Comparing predictive drug nephrotoxicity biomarkers in kidney 3-D primary organoid culture and immortalized cell lines [J].
Astashkina, Anna I. ;
Mann, Brenda K. ;
Prestwich, Glenn D. ;
Grainger, David W. .
BIOMATERIALS, 2012, 33 (18) :4712-4721